Please join us for a compelling discussion about the rare, unusual thrombotic events that develop in association with thrombocytopenia approximately one to two weeks after vaccination with a SARS-CoV-2 vaccine.
Posts - Thrombophilia
Aug 31, 2021 1:06pm
Aug 6, 2021 9:28am
From Crystal Wilson: Hello George, I am writing to ask if you could help me to understand how, on rare occasions, patients suffering from bleeding disorders such as von Willebrand disease or hemophilia have suffered from hypercoagulable episodes such as pulmonary emboli or deep vein thrombosis. Thanks.
Aug 3, 2021 8:48am
Our July, 2021 Quick Question was, "Which cell is the main cause of thrombo-inflammation in a COVID-19 infection?" We had 43 respondents to our selections:
Jul 11, 2021 12:03pm
Here is a research article that was rushed to print in the July 7, 2021 Nature that describes the precise pathophysiology of vaccine-induced immune thrombotic thrombocytopenia [VITT]. VITT is the critical 1/60,000 incidence adverse event associated with the adenoviral vector employed in the Astra-Zeneca and Johnson and Johnson vaccines, among others.